Standard heart failure therapy involving eplerenone or metoprolol was shown to be ineffective in PLN-Arg14del heterozygous mice (Eijgenraam et al., 2020), underscoring the need for the development of novel therapeutic strategies targeting PLN-Arg14del. Here, PLN is linked to heart failure.